摘要
目的:探讨超声联合甲胎蛋白(AFP)检测在肝癌高危人群中诊断价值。方法:178例肝癌高危人群,分别采用腹部超声和AFP辅助诊断,以病理检查结果为金标准,分析灵敏度、特异性及阳性符合率。结果:B超检查灵敏度、特异度、诊断符合率分别为53.13%、94.52%、87.08%,AFP检查分别为43.75%、89.73%、81.46%,B超联合AFP检查分别为81.25%、91.10%、89.33%。结论:B超和甲胎蛋白联合检查提高肝癌高危人群中筛查灵敏度和阳性符合率。
Objective：To investigate the diagnostic value of ultrasonic combined with alpha-fetoprotein（AFP） in liver cancer high risk population.Methods：178 cases of hepatocellular carcinoma were diagnosed by abdominal ultrasonic and AFP.The sensitivity,specificity and positive coincidence rate were analyzed by gold standard based on the results of pathological examination.Results：The sensitivity,specificity and diagnose accordance rate were respectively 53.13%,94.52%,87.08% for type-B ultrasonic test; 43.75%,89.73%,81.46% for AFP test.81.25%,91.10%,89.33% for type-B ultrasonic combined with alpha-fetoprotein test.Conclusion：Type-B ultrasonic combined with alpha-fetoprotein test improves both screening sensitivity and positive coincidence rate in liver cancer high risk population.
出处
《华夏医学》
CAS
2017年第1期70-73,共4页
Acta Medicinae Sinica
关键词
肝癌高危人群
B超
甲胎蛋白
筛查
liver cancer high risk population
type-B ultrasonic
alpha-fetoprotein（AFP）
screening
